日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Absence of copy number gain of EGFR: A possible predictive marker of long-term response to afatinib

EGFR拷贝数增加缺失:可能是阿法替尼长期疗效的预测标志物

Nakamura, Tomomi; Sato, Akemi; Nakashima, Chiho; Abe, Tomonori; Iwanaga, Kentaro; Umeguchi, Hitomi; Kawaguchi, Atsushi; Sueoka-Aragane, Naoko

The role of comprehensive analysis with circulating tumor DNA in advanced non-small cell lung cancer patients considered for osimertinib treatment

循环肿瘤DNA综合分析在考虑接受奥希替尼治疗的晚期非小细胞肺癌患者中的作用

Sueoka-Aragane, Naoko; Nakashima, Chiho; Yoshida, Hironori; Matsumoto, Naohisa; Iwanaga, Kentaro; Ebi, Noriyuki; Nishiyama, Akihiro; Yatera, Kazuhiro; Kuyama, Shoichi; Fukuda, Minoru; Ushijima, Sunao; Umeguchi, Hitomi; Harada, Daijiro; Kashiwabara, Kosuke; Suetsugu, Takayuki; Fujimoto, Nobukazu; Tanaka, Fumihiro; Uramoto, Hidetaka; Yoshii, Chiharu; Nakatomi, Katsumi; Koh, Genju; Seki, Nobuhiko; Aoe, Keisuke; Nosaki, Kaname; Inoue, Koji; Takamori, Ayako; Kawaguchi, Atsushi

Development of Acquired Hemophilia A After Treatment of Bronchial Asthma with Benralizumab

使用贝那利珠单抗治疗支气管哮喘后发生获得性血友病A

Kitamura, Hiroaki; Kubota, Yasushi; Tomimasu, Rika; Hirakawa, Haruki; Inoue, Hiroshi; Umeguchi, Hitomi; Yoshida, Moeko; Akahoshi, Hideki; Tsuruda, Shiho; Ide, Rie; Kimura, Shinya; Miyahara, Masaharu

Plasma T790M and HGF as potential predictive markers for EGFR-TKI re-challenge

血浆T790M和HGF作为EGFR-TKI再挑战的潜在预测标志物

Nakamura, Tomomi; Watanabe, Naomi; Sato, Akemi; Komiya, Kazutoshi; Umeguchi, Hitomi; Hosomi, Toshiya; Hirai, Mitsuharu; Sueoka, Eisaburo; Kimura, Shinya; Sueoka-Aragane, Naoko

SPARC is a possible predictive marker for albumin-bound paclitaxel in non-small-cell lung cancer

SPARC可能是预测非小细胞肺癌中白蛋白结合型紫杉醇疗效的标志物。

Komiya, Kazutoshi; Nakamura, Tomomi; Nakashima, Chiho; Takahashi, Koichiro; Umeguchi, Hitomi; Watanabe, Naomi; Sato, Akemi; Takeda, Yuji; Kimura, Shinya; Sueoka-Aragane, Naoko